HOFFMAN; Amnon
Patent Applications and Registrations
Patent applications and USPTO patent grants for HOFFMAN; Amnon.The latest application filed is for "par4 derived peptides, analogs and uses thereof".
- HOFFMAN; Amnon - Jerusalem IL
| Patent | Date |
|---|---|
| Par4 Derived Peptides, Analogs And Uses Thereof App 20220119474 - BAR-SHAVIT; Rachel ; et al. | 2022-04-21 |
| Somatostatin prodrugs Grant 11,261,215 - Hoffman , et al. March 1, 2 | 2022-03-01 |
| Lipophilic Peptide Prodrugs App 20220016218 - HOFFMAN; Amnon ; et al. | 2022-01-20 |
| Sustained-release Injectable Antibiotical Formulation App 20210315803 - FRIEDMAN; Michael ; et al. | 2021-10-14 |
| Sustained-release injectable formulation Grant 11,052,043 - Friedman , et al. July 6, 2 | 2021-07-06 |
| Lipophilic Peptide Prodrugs App 20200323962 - HOFFMAN; Amnon ; et al. | 2020-10-15 |
| N-methylated Cyclic Peptides And Their Prodrugs App 20200283483 - KESSLER; Horst Otto ; et al. | 2020-09-10 |
| Somatostatin Prodrugs App 20200262871 - HOFFMAN; Amnon ; et al. | 2020-08-20 |
| Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (MyD88) Grant 10,662,225 - Nussbaum , et al. | 2020-05-26 |
| Formulation And Method For Increasing Oral Bioavailability Of Drugs App 20200009067 - HOFFMAN; Amnon ; et al. | 2020-01-09 |
| Backbone Cyclized Inhibitory Peptides Of Myeloid Differentiation Factor 88 (myd88) App 20190185516 - NUSSBAUM; Gabriel ; et al. | 2019-06-20 |
| Novel Cannabinoid Formulations App 20180325861 - DOMB; Abraham J. ; et al. | 2018-11-15 |
| Methods and compositions for the treatment of bone remodeling disorders Grant 9,725,484 - Holoshitz , et al. August 8, 2 | 2017-08-08 |
| Compositions and methods for inducing an immune response Grant 9,555,086 - Holoshitz , et al. January 31, 2 | 2017-01-31 |
| Methods And Compositions For The Treatment Of Bone Remodeling Disorders App 20160002295 - Holoshitz; Joseph ; et al. | 2016-01-07 |
| Carbamoylphosphonates as inhibitors and uses thereof Grant 8,993,544 - Breuer , et al. March 31, 2 | 2015-03-31 |
| Formulation And Method For Increasing Oral Bioavailability Of Drugs App 20140348926 - Hoffman; Amnon ; et al. | 2014-11-27 |
| Compositions And Methods For Inducing An Immune Response App 20140212444 - Holoshitz; Joseph ; et al. | 2014-07-31 |
| Compositions and methods for inducing an immune response Grant 8,658,603 - Holoshitz , et al. February 25, 2 | 2014-02-25 |
| Sustained-release Injectable Formulation App 20140018323 - Friedman; Michael ; et al. | 2014-01-16 |
| Oral Sustained Release Formulation Of Huperzine A App 20130040982 - Friedman; Michael ; et al. | 2013-02-14 |
| Macrocyclic Compounds, Compositions Comprising Them And Methods For Preventing Or Treating Hiv Infection App 20120270774 - Gilon; Chaim ; et al. | 2012-10-25 |
| Carbamoylphosphonates As Inhibitors And Uses Thereof App 20120035140 - Breuer; Eli ; et al. | 2012-02-09 |
| Backbone Cyclized Melanocortin Stimulating Hormone (Alpha Msh) Analogs App 20080242600 - Gilon; Chaim ; et al. | 2008-10-02 |
| Gastro-Retentive Diagnostic Assemblies App 20080206145 - Afargan; Michel ; et al. | 2008-08-28 |
| Gastroretentive controlled release pharmaceutical dosage forms Grant 6,685,962 - Friedman , et al. February 3, 2 | 2004-02-03 |
| Gastroretentive controlled release pharmaceutical dosage forms App 20030021845 - Friedman, Michael ; et al. | 2003-01-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 